摘要 |
<p>The invention relates to the use of antibodies, which bind to antibodies for tumour-associated antigens and which are obtained from individual body fluids by immuno-affinity purification with specific ligands, for the production of individual, autologous, prophylactic or therapeutic vaccination against cancerous disease states. The ligands for immuno-affinity purification are antibodies or derivatives thereof, to tumour associated antigens. The invention further relates to pharmaceutical compositions, which comprise the antibodies produced by immuno-affinity purification, or the dendritic cells pulsed in-vitro by said antibodies.</p> |